This website is operated by Amgen Canada Inc. ("Amgen Canada"), a wholly-owned subsidiary of Amgen Inc., a leading biopharmaceutical company involved in the research, development and marketing of biopharmaceuticals in Canada. Amgen Canada values the relationship it has with healthcare professionals and patients/consumers. We are committed to protecting the personal information that individuals entrust us with.
Amgen Canada is bound by the Personal Information Protection and Electronic Documents Act ("PIPEDA") and applicable provincial privacy legislation. This legislation is designed to protect the confidentiality of personal information and the privacy of individuals by regulating the way personal information is collected, used, disclosed and otherwise managed.
Information about PIPEDA, as well as links for resources about applicable provincial privacy legislation, may be accessed from the website of the Office of the Federal Privacy Commissioner at http://www.priv.gc.ca/
Amgen Canada collects personal information for many aspects of its activities, including the following:
Patients may participate in clinical trials of biopharmaceutical products as part of Amgen Canada's medical research and development programs. The trials are conducted by hospitals or other institutions, but are funded and supported by Amgen Canada. Patients who participate in these clinical trials provide express written consent to the manner in which their personal information will be collected, used, transferred, accessed and/or disclosed in connection with the research related to the trial.
Generally, Amgen Canada only receives de-identified information relating to clinical trial patients from physicians and investigators conducting the clinical trial. Personal identifiers related to this information, such as the patient's name and residential address, are not collected by Amgen Canada except in limited circumstances and only with the patient's express consent. These circumstances include certain clinical trials where Amgen Canada employees or its authorized contractors may view personal information at a clinical trial site to audit and/or monitor the trial and to comply with regulatory requirements.
In general, Amgen Canada uses personal information for the following purposes:
There may be circumstances where Amgen Canada shares your personal information with third party contractors and service providers (including affiliates of Amgen Canada) that are located outside Canada. In particular, your personal information may be stored on servers in the United States, Europe and other countries and may therefore be subject to other additional local legislation. Other jurisdictions, including the United States, may have laws and regulations that require the disclosure of personal information to governmental authorities under different circumstances than would Canada.
Amgen Canada may disclose personal information to third party manufacturers and service providers in circumstances involving a product or service complaint received by Amgen Canada, or to regulatory bodies where Amgen Canada is under a legal obligation to provide personal information. Amgen Canada may also disclose personal information for the purposes of an emergency that threatens the life, health or security of an individual. If such a disclosure is made, Amgen Canada will notify the individual about whom personal information was disclosed.
In addition, we must provide your personal information in response to a search warrant or other legally valid inquiry or order, or to an investigative body in the case of a breach of an agreement or contravention of law, or as otherwise required by law. Amgen Canada may also disclose personal information to assist us in collecting a debt owed by you.
Amgen Canada reserves the right to transfer any information we have about you in the event we merge with, sell or transfer all or a portion of our business or assets to another party.
Accessing personal information Amgen Canada holds about you.
You may seek access to the personal information Amgen Canada holds about you by submitting an access request in writing to Amgen Canada at the address set out below. Amgen Canada will endeavour to process written requests within a reasonable time and in any event within thirty (30) days of receipt of the request unless Amgen Canada notifies you otherwise. Amgen Canada will provide your personal information to you at no cost or, under certain circumstances, at a minimal cost, but only after having advised you of this cost and given you an opportunity to withdraw your request. In certain circumstances Amgen Canada is entitled to deny access, in situations where:
Amgen Canada endeavours to ensure that the personal information it holds is accurate, complete and up-to-date.
The protection of your privacy and the safety of your personal information is very important to Amgen Canada. We will retain your personal information only for the time it is required for the purpose for which it was collected and to comply with applicable laws. We will securely destroy obsolete personal information.
Chief Privacy Officer
Postal Address: Amgen Canada, 6775 Financial Dr., Suite 100, Mississauga, Ontario L5N 0A2
Pour la version française de l'avis sur la protection des renseignements personnels, cliquez ici.
Last updated: January 2016.
"You need to read as much as you can. It's your body; it's your disease."
—Lindagail D., ENBREL RA patient
With Enliven, you have free access to nurses, weekdays 8:00 am to 8:00 pm EST